SCHEMBL2992060

SCHEMBL2992060

COCn1c(-c2ccccc2)c(C2CCCCC2)c2sc(C(=O)O)cc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 2/20 0.34
KDM4E B2RXH2 2/20 0.33
POLB P06746 2/20 0.33
HSD17B10 Q99714 1/20 0.33
USP2 O75604 1/20 0.33
MAPK8 P45983 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
PDE4D Q08499 2/20 0.32
PDE7A Q13946 2/20 0.32
RAB9A P51151 1/20 0.32
ERCC5 P28715 1/20 0.32
FEN1 P39748 1/20 0.32
CNR1 P21554 2/20 0.32
CNR2 P34972 2/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2998826 0.94 KDM4E (0.36) FABP4KDM4EPOLBMAPK8HTT
SCHEMBL2994261 0.91 PTGDR2 (0.34) ERCC5FEN1CNR1TP53MAPT
SCHEMBL13211483 0.86 FABP4 (0.38) FABP4KDM4EPOLBHSD17B10USP2
SCHEMBL27642142 0.86 FABP4 (0.35) FABP4POLBHSD17B10USP2PDE4D
SCHEMBL2998608 0.85 CNR1 (0.37) FABP4KDM4EPOLBUSP2HTT
SCHEMBL13211509 0.84 FABP4 (0.34) FABP4KDM4EPOLBHSD17B10USP2
SCHEMBL2998221 0.84 NR1H4 (0.37) KDM4ERAB9ACNR1MAPTKMT2A
SCHEMBL2994392 0.84 KDM4E (0.40) FABP4KDM4EPOLBUSP2MAPK8
SCHEMBL2997714 0.84 MAPT (0.38) FABP4MAPT
SCHEMBL13211487 0.84 ALDH1A1 (0.39) FABP4KDM4EPOLBHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US disclosed
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US disclosed
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US disclosed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US disclosed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US disclosed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US disclosed
EP-1664059-B1 THIENOPYRROLES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2007-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036443-A1 Thienopyrroles as antiviral agents ZC3HAV1, XDH, TPMT FABP4 4455/4885KDM4E 3250/4885POLB 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.